Federal charges filed against Dallas compounding pharmacy

Five years after three patients died from an overdose of a mislabeled gout drug, the Justice Department has filed federal misdemeanor charges against the compounding pharmacy that made it. The charges against ApotheCure of Dallas were filed at the request of the FDA. Justice maintains FDA tests found some vials shipped to a now-defunct medical center in Oregon contained 640% more colchicine than the label said, while others were subpotent by 62%. Pharmalot points out the case has raised questions about the lax oversight of compounding pharmacies. In a chilling tale of greed and drugs detailed in The New York Times Magazine, pharmacist Robert Courtney, who owned a compounding pharmacy in Kansas City, diluted 98,000 prescriptions, including cancer drugs. Some of the patients died, and Courtney was sentenced to up to 30 years in federal prison. Piece | Justice release | Story

Suggested Articles

McCallum was hit with a warning letter from the FDA for testing issues with its products and failing to keep appropriate records.

Cambrex has completed installation of multiple continuous flow reactor platforms at its facility in High Point, North Carolina.

Australia’s Mayne Pharma has opened its $80 million oral solid-dose manufacturing facility in Greenville, North Carolina.